A Highlight of Recent Advance in Immunology
A Highlight of Recent Advance in Immunology
出处
《生物化学与生物物理进展》
SCIE
CAS
CSCD
北大核心
2011年第12期1111-1112,共2页
Progress In Biochemistry and Biophysics
参考文献8
-
1LIU Yang1,2,CHEN GuoYun2,ZHENG Pan2 & TANG Jie11 Key Laboratory of Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China 2Departments of Surgery,Internal Medicine and Pathology,University of Michigan at Ann Arbor,MI48109,USA.On self-nonself discrimination in pattern recognition[J].Science China(Life Sciences),2010,53(2):169-171. 被引量:7
-
2WANG YaYa1,ZHANG Peng2,LIU YingFang2 & CHENG GenHong1 1 Department of Microbiology,Immunology & Molecular Genetics,University of California Los Angeles,609 Charles E.Young Drive East,Los Angeles,California 90095,USA,2 National Laboratory of Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China.TRAF-mediated regulation of immune and inflammatory responses[J].Science China(Life Sciences),2010,53(2):159-168. 被引量:21
-
3TANG Hong1 & FU YangXin1,2 1 Key Laboratory of Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China,2 Department of Pathology,Committee of Immunology,University of Chicago,Chicago,IL 60637,USA.A new role for T cells in dampening innate inflammatory responses[J].Science China(Life Sciences),2010,53(2):190-194. 被引量:9
-
4TANG Fei1,2,DU Qiumei1,2 & LIU Yong-Jun3 1 Center for Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China,2 Graduate University of Chinese Academy of Sciences,Beijing 100049,China,3 Department of Immunology and Center for Cancer Immunology Research,University of Texas,M.D.Anderson Cancer Center,Houston,Texas 77030,USA.Plasmacytoid dendritic cells in antiviral immunity and autoimmunity[J].Science China(Life Sciences),2010,53(2):172-182. 被引量:23
-
5刘星,石贺欣,王琛.干扰素调控因子3:细胞抗病毒反应的核心转录因子[J].生物化学与生物物理进展,2010,37(8):817-825. 被引量:4
-
6MEISSNER Eric.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis[J].Science China(Life Sciences),2010,53(2):195-203. 被引量:12
-
7孙冰,韩代书.Toll样受体信号通路的负调控[J].生物化学与生物物理进展,2009,36(12):1516-1522. 被引量:31
-
8WANG ShengDian1 & CHEN LiePing1,2 1Center for Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China,2Department of Oncology,Johns Hopkins University School of Medicine,Baltimore,Maryland,USA.Structural immunology of costimualtory and coinhibitory molecules[J].Science China(Life Sciences),2010,53(2):183-189. 被引量:8
二级参考文献362
-
1王海坤,韩代书.Toll样受体(TLRs)的信号转导与免疫调节[J].生物化学与生物物理进展,2006,33(9):820-827. 被引量:60
-
2Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci, 2008, 1143:21-34.
-
3Wang J, Hu Y, Deng W W, et al. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect, 2009, 11(3): 321 -327.
-
4O'Neill L A, Bowie A G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol, 2007, 7 (5): 353-364.
-
5Creagh E M, O'Neill L A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol, 2006, 27(8): 352-357.
-
6Kuroishi T, Tanaka Y, Sakai A, et al. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol, 2007, 44(8): 1969-1976.
-
7Fernandez-Fernandez L, Bellido-Martln L, Garcfa de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost, 2008, 100 (4): 604-610.
-
8O'Neill L A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev, 2008, 226( 1): 10- 18.
-
9Sweet M J, Leung B P, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol, 2001, 166(11): 6633-6639.
-
10Takezako N, Hayakawa M, Hayakawa H, et al. ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun, 2006, 341(2): 425-432.
共引文献76
-
1李洁,郑小松.基于网络分析的鱼腥草毒性作用机制[J].沈阳药科大学学报,2019,36(11):1047-1055. 被引量:4
-
2张子剑,潘荣,周园,赫荣乔.酶促反应的“诱导契合-锁钥”模式[J].生物化学与生物物理进展,2011,38(5):418-426. 被引量:12
-
3武前枝,张志红.机械通气肺损伤与ASK1、TLR2/4的关系[J].临床肺科杂志,2011,16(8):1243-1245. 被引量:3
-
4郭腾飞,黄旭雄,苏明,王武刚,怀向军,胡盼,严佳琦,吕丹,黄征征.饲料锌添加水平对凡纳滨对虾免疫抗菌机能和溶菌酶mRNA及Toll受体mRNA表达的影响[J].水产学报,2011,35(7):1081-1089. 被引量:11
-
5CHANG Zeng-Yi.Science China Life Sciences in 2010: a New Name Marking a New Start[J].生物化学与生物物理进展,2011,38(9):804-809.
-
6贾连群,冯峻屹,杨关林,刘春英,曹阳,张林.丹参酮ⅡA对EA.hy926细胞TLR4/NF-κB炎症信号通路的影响[J].中国生化药物杂志,2011,32(5):337-340. 被引量:16
-
7常晓彤,辇晓峰,王振辉.Toll样受体信号转导途径研究进展[J].生理科学进展,2011,42(5):340-346. 被引量:61
-
8ZENG ZhaoYang,HUANG HongBin,ZHANG WenLing,XIANC Bo,ZHOU Ming,ZHOU YanHong,MA Jian,YI Mei,LI XiaYu,LI XiaoLing,XIONG Wei,LI GuiYuan.Nasopharyngeal carcinoma:Advances in genomics and molecular genetics[J].Science China(Life Sciences),2011,54(10):966-975. 被引量:13
-
9奇云,李大可.机体的免疫反应是如何被激活的?——2011年诺贝尔生理学或医学奖解读[J].生物化学与生物物理进展,2011,38(10):900-907. 被引量:2
-
10殷琪立,何睿.Chemerin免疫调节作用的研究进展[J].国际免疫学杂志,2011,34(6):345-348. 被引量:1
-
1LOOK BACK ON THE PAST,ADVANCE BRAVELY IN THE FUTNRE[J].南亚研究季刊,1994(3):3-6.
-
2艾德里安.史密斯.3R和替代方法是否进行了有效的探究(英文)[J].中国实验动物学报,2015,23(5):543-550. 被引量:1
-
3Advance International S&T Cooperation and Exchanges——An Interview with TWAS President-elect BAI Chunli[J].Bulletin of the Chinese Academy of Sciences,2012,26(4):245-247.
-
4让中国孩子分享Highlights的美妙阅读世界——印刷工业出版社Highlights系列童书新闻发布会[J].全国新书目,2012(8):10-10.
-
5曾民族.对科技信息服务的再认识[J].中国信息导报,2003(10):15-18. 被引量:10
-
6LIU Yan-ze McLean Hospital/Harvard Medical School, Belmont, MA 02478, USA.Highlight of Publications on Chinese Traditional and Herbal Drugs in 2008[J].Chinese Herbal Medicines,2009,1(1):40-44. 被引量:1
-
7魏莎莎,任丹青,郑芹珠,刘晓雁,马蓉蓉.栏目创新活跃学术 名家荟萃激发思考 信息云集服务读者——《亚洲男性学杂志》栏目创新实践[J].中国科技期刊研究,2012,23(6):1040-1042. 被引量:2
-
8Kijlstra Aize,Yang Peizeng.Immunology of age related macular degeneration[J].重庆医学,2011,40(6):523-527.
-
9我国科学家发现天然免疫识别与调控新机制[J].黑龙江科学,2013,4(8):8-8.
-
10丁一.日本《著作权事典》摘译[J].出版发行研究,1985(1):47-49.